南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

PRMT6通过促进不对称的精氨酸二甲基化介导的FOXG1降解并抑制线粒体自噬,从而导致听力损失。

PRMT6 drives hearing loss by promoting asymmetric arginine dimethylation-mediated FOXG1 degradation and suppressing mitophagy

Jin Wu, Zhi Liu

Journal:EXPERIMENTAL GERONTOLOGY

IF:5.1

DOI:10.1016/j.exger.2026.113278

PMID:42586389

Published:2026-08-12

research field:药理学细胞生物学遗传学与基因组学眼科学

Abstract

PRMT6 inhibition reduces cochlear senescence in aging mice. • PRMT6 knockdown restores mitochondrial function in D-gal-induced senescence HEI-OC1 cells. • PRMT6-driven FOXG1 methylation stifles mitophagy, fueling D-gal-induced cochlear senescence. • The PRMT6-FOXG1 axis is a potential target against ARHL. Objective Age-related hearing loss (ARHL) is a progressive and irreversible sensorineural impairment with incompletely understood mechanisms. This study investigates the role of protein arginine methyltransferase 6 (PRMT6) and its regulatory mechanisms in ARHL. Methods In vivo , D-galactose (D-gal)-induced aging mouse models were established. Auditory brainstem response (ABR), cochlear β-galactosidase activity, and PRMT6 expression were measured, and the therapeutic effects of the PRMT6 inhibitor EPZ020411 were evaluated. In vitro , D-gal-treated HEI-OC1 cells were employed. PRMT6 was silenced using siRNA. Cellular senescence and apoptosis were assessed by SA-β-gal staining and TUNEL assay. Mitochondrial function was evaluated by JC-1 staining, ROS levels, ATP content, and transmission electron microscopy. Mitophagy was determined by LC3-TOM20 co-localization and the GFP-LC3-RFP-LC3ΔG reporter system. Asymmetric arginine dimethylation of FOXG1 was measured by immunoprecipitation with the D6A8 antibody, and FOXG1 protein stability was assessed by a cycloheximide chase assay. Results Aging mice exhibited elevated ABR thresholds, increased β-gal activity, and upregulated PRMT6, all reversed by EPZ020411. PRMT6 silencing attenuated cellular senescence and apoptosis, improved mitochondrial membrane potential, elevated ATP content, reduced ROS accumulation, and ameliorated mitochondrial damage. PRMT6 silencing also enhanced autophagic flux. Notably, PRMT6 silencing did not alter FOXG1 mRNA but upregulated FOXG1 protein and decreased its asymmetric arginine dimethylation, prolonging FOXG1 half-life. FOXG1 knockdown partially reversed the enhanced mitophagy, impaired mi

本文使用的Yeasen产品

购物车
客服
转染试用